This compound is a chemical compound used as a pharmaceutical intermediate. It is primarily significant in the manufacturing of kinase inhibitors for research and development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1236033-21-8
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
3-Amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
Pharmaceutical intermediate for kinase inhibitors
4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic Acid
Pharmaceutical intermediate
(S)-3-Hydroxybutanenitrile
pharmaceutical intermediate
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
chiral intermediate for active pharmaceutical ingredients
(S)-2-Benzyl-3-(benzyloxy)propanoic acid
Impurity standard for Alvimopan
tert-butyl 4-chloropyrrolo[2,3-d]pyrimidine-7-carboxylate
XGGUTWYJGILAOA-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1C=CC2=C1N=CN=C2Cl